Portfolio company
Evinature
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops and sells herbal nutraceuticals and tailored gut health protocols for patients with inflammatory bowel disease and gastrointestinal conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gut Wealth
This company manufactures digestive health supplements, including postbiotic capsules and liquid sachets, for individuals suffering from irritable bowel syndrome and digestive discomfort.
Apriwell
This company provides gastrointestinal supplements and a digital therapy app for individuals suffering from chronic constipation and digestive health conditions.
BIOKURIS
The company develops biopolymer-based medical nutrition products for business-to-business customers to manage chronic gastrointestinal conditions such as irritable bowel syndrome.
EnteroBiotix
This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.
Epetome
This company produces gut health supplements for consumers seeking scientifically validated probiotic and prebiotic products to improve digestive wellness.
Vitract
Vitract provides gut microbiome testing kits and personalised nutrition guidance for consumers and healthcare practitioners to improve digestive health and overall wellbeing.
InnerBuddies
This company provides microbiome analysis kits and nutritional advice for consumers and corporate health partners seeking to improve gut health and well-being.
